The digital pathology market is expected to grow from US$ 852.08 million in 2021 to US$ 1,892.40 million by 2028; it is estimated to grow at a CAGR of 12.1% from 2021 to 2028.
The digital pathology market is expected to grow from US$ 852.08 million in 2021 to US$ 1,892.40 million by 2028; it is estimated to grow at a CAGR of 12.1% from 2021 to 2028.
Digital pathology comprises the gaining, organizing, sharing, and interpretation of pathology information. The process involves converting the glass slides into digital pathology slides using digital pathology scanning solutions. A digital slide image file is then generated, which allows the high resolution viewing, interpretation, and image analysis of digital pathology slides.
The digital pathology market is segmented on the bases of product, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the analysis of competitive landscape of the globally leading market players.
Request for sample copy at: https://www.theinsightpartners.com/sample/TIPHE100000855/
Digital pathology Market Competitive Landscape and Key Development
- Based on product, the global digital pathology market is segmented into scanners, software, storage, communication systems. In 2020, the scanners segment held the largest share of the market. However, the software segment is expected to register the highest CAGR during 2021–2028. Scanner helps in producing quick, reliable, and high-resolution images of cells.
- It also helps pathologists, histologists, and other medical professionals to scan slides and upload an image on the network for remote access and to collaborate it among the peers. The market for the scanners segment is anticipated to grow in the future owing to the increasing use of scanners in digital pathology.
- Based on application, the global digital pathology market is segmented into telepathology, disease diagnosis, drug discovery, and training and education. In 2020, the drug discovery segment held the largest share of the market. However, the same segment is expected to register the highest CAGR during 2021–2028.
The market growth for the drug discovery segment is attributed to factors such as the central benefit of digital pathology in pharmaceutical research to apply image analysis algorithms for reducing subject interpretations, growing awareness about neurological disorders, and the availability of advanced EEG products. This is critically important to automate dull tasks such as counting cells of interest or estimating protein expression in immunohistochemical assays. Thus, owning to these factors companies also contribute in generating the revenues and for the market growth for the digital pathology segment.
A few prominent players operating in the digital pathology market are Koninklijke Philips N.V.; Nikon Corporation; Perkin Elmer, Inc.; Indica Labs; 3DHISTECH Ltd.; Danaher; Hamamatsu Photonics K.K.; F. HOFFMANN-LA ROCHE LTD.; Visiopharm A/S; and Glencoe Software, Inc.
Companies are launching new and innovative products and services to sustain their position in the digital pathology market. In May 2020, Danahar (Leica Biosystems) launched the Aperio GT 450 DX, its next generation digital pathology scanner, in APAC. With continuous loading, no-touch operation, and 32 second scan time at 40x magnification, the Aperio GT 450 DX (registered as CE IVD and TGA) allows healthcare organizations to scale up digital pathology so that they can meet increasing demands without sacrificing quality.
Growing Preference for Telepathology in Remote Areas Contributes Significantly to Market Growth
People staying in remote regions need to travel to urban areas for disease diagnosis, treatment, and follow-up, which is a major concern faced by them. Digital pathology helps bridge the gap between the patients and diagnosing centers, as it provides the people staying in remote areas with an effective access to healthcare organizations; it also helps save time and money of patients. In addition, the digital pathology setup is easy to adopt in rural labs and hospitals. Further, Telepathology strives to bridge the gap between two or more geographically distant healthcare providers by eliminating geographic and functional distances. It is described as a remote telecommunications consultation, primarily, for the diagnosis or treatment of patients. Several hospitals, primary care providers, private clinics, and other medical institutions are offering Telepathology services. Thus, it has emerged as a viable and effective option for reducing costs, benefiting organizations, and ensuring improved patient satisfaction. Thus, the growing acceptance for Telepathology is fueling digital pathology market growth.
Buy Complete Report at: https://www.theinsightpartners.com/buy/TIPHE100000855/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com